The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
Since tirzepatide's effectiveness depends on consistent absorption, spacing your moringa doses away from injections and maintaining stable timing patterns reduces absorption uncertainty
PlexusDx patients receive detailed guidance on managing this response and determining whether adjustments are needed
S., Carrasco-Pozo, C., Hodson, M
But if you have the extra money and are wanting to reap any of the benefits outlined above, go ahead